Pharmaceutical product R&D and Production

NT Pharma's production plant is situated in Suzhou, China, which occupies a 3,800,000 square meters. The plant is equipped with GMP-certified facilities which specialize in the production of dry powders for injection, active pharmaceutical ingredients (APIs) and other raw materials. Besides, the Group possesses 164 SFDA licenses for the production of various pharmaceutical products including antibiotics, anti-psychotic and cardiovascular drugs.

The construction project of new plant in Suzhou Industrial Park compiled with EU and FDA standard is on the way. The new plant, equipped with facilities with latest technology will not only serve for the production of APIs and own-brand products, but also the OEM from multinational pharmaceutical corporations.

Development of own-brand products is one of the future strategies of the Group. Co-operating with academic institutions, the Group is striving on the development of a proprietary, new Class I protein-based drug. Upon successful launch, such products are expected to bring enormous economic and social benefits to China.